Transactions
Showing 631-645 of 935 items
-
C$6m
Sunniva
Sole Bookrunner (Equity Follow-on)
-
US$156m
Halt Medical
Financial Advisor to Company on its §363 sale to Murray Enterprises, LLC and S3 Ventures, LLC
-
N/a
Lucid Group
Financial Advisor (Sell side)
-
N/a
Halt Medical, Inc
Financial Advisor to Halt Medical, Inc. on its sale to Acessa Health, Inc. pursuant to §363 of the U.S. Bankruptcy Code
-
US$40m
Savara
Lead Manager (CMPO)
-
N/a
Sonoma Orthopedic Products, Inc.
Financial Advisor to Sonoma Orthopedic Products, Inc. on its sale to Arthrex, Inc.
-
N/a
Savara Inc.
Financial Advisor to Savara Inc. on its merger with Mast Therapeutics
-
C$6m
InMed Pharmaceuticals
Sole Bookrunner (Follow-on)
-
C$5m
Delta 9 Cannabis
Sole Bookrunner (Follow-on)
-
C$25m
Invictus MD Strategies
Sole Bookrunner (Follow-on)
-
N/a
Intact
Financial Advisor on its sale to Medtronic
-
N/a
INC Research
Financial Advisor (Sell side)
-
A$33m
Visioneering Technologies, Inc.
Lead Manager (IPO)
-
A$14m
CANN Group Limited
Joint Lead Manager (IPO)
-
N/a
Informatics Corporation of America
Financial Advisor to Informatics Corporation of America on its sale to SSI